(Fort Worth, TX) — HEALTHPOINT, Ltd., a Texas-based market leader in tissue management, surgical, and dermatology products, has introduced the first unit dose packaging of its popular prescription ointments Panafil® and Accuzyme®---in bar coded six-gram units to complement the standard 30 gram tubes.

        Accuzyme is an enzymatic debriding ointment used to treat necrotic wounds, pressure ulcers and burns by removing dead tissue without harming living tissue. Panafil is a healing, debriding, and deodorizing ointment that promotes healing, controls local inflammation and reduces wound odors.

        “Chronic wounds affect millions of people every day,” said Richard Rudman, wound management marketing director for Healthpoint’s Tissue Management Division. “These new six gram unit doses give health care providers and patients a safe, easy option for first time applications and for situations that require less therapy.”

        Panafil and Accuzyme are backed by years of use, clinical support, and a proven formula, according to Mr. Rudman. The new packaging also reduces potential waste, he said. Healthpoint is offering these products in unit dose to provide convenience, to all those who have benefited over the years from the original 30g versions of each.

        Unit doses for Panafil® and Accuzyme® will be available February 1 to distributor/drug wholesalers across the United States. Panafil and Accuzyme are generally well tolerated by patients using these products however upon application a small percentage of patients may experience a brief stinging sensation.

        Since its inception in 1992, HEALTHPOINT has established a national presence in the research, development, and marketing of branded pharmaceuticals, over the counter drugs, and medical devices for the tissue management, dermatology, and surgical. An aggressive research and development effort has brought HEALTHPOINT’s unique technologies to the market, setting the pace for its highly trained national field sales organization of direct sales representatives. HEALTHPOINT, with over 250 employees, is a DFB Pharmaceuticals, Inc. affiliate company.

        Based in Fort Worth, Texas, DFB provides technology-driven products, outsourcing services and licensing opportunities to the healthcare industry worldwide through its affiliate companies, contract partners, and branded marketing organizations.

        HEALTHPOINT headquarters are in Fort Worth, with an additional office in Canada.

        Visit HEALTHPOINT’s web site at www.HEALTHPOINT.com.

###